Clinical trial
Clinical Effectiveness of Combined Arthrocentesis With Intra-articular Injection of Meloxicam in Treatment of Temporomandibular Joint Internal Derangement
NCT07743684 is registered in ClinicalTrials.gov with Hussein Mohammed Ridha as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Effectiveness of Combined Arthrocentesis With Intra-articular Injection of Meloxicam in Treatment of Temporomandibular Joint Internal Derangement
- Lead sponsor
- Hussein Mohammed Ridha
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- January 1, 2026
- Completion date
- October 31, 2027
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
temporomandibular joint internal derangement